New treatment offers better outlook for aggressive brain tumor patients

Researchers from UZ Brussels and Vrije Universiteit Brussel (VUB) report encouraging long-term results with an experimental immunotherapy. The treatment was studied in patients with a recurrent, aggressive brain tumor. According to the researchers, the long-term results offer a better outlook for this patient group. The treatment remains experimental and is not yet routinely available.